Is Stryker Stock Underperforming the Dow?

Portage, Michigan-based Stryker Corporation (SYK) operates as a medical technology company that develops, manufactures, and markets specialty surgical and medical products. Valued at $149.6 billion by market cap, the company's products include implants, surgical, neurologic, ear, nose and throat and interventional pain equipment, endoscopic, surgical navigation, digital imaging systems, as well as patient handling and emergency medical equipment.

Companies worth $10 billion or more are generally described as “large-cap stocks,” and SYK perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the medical devices industry. Stryker is a leading medical technology company, driving innovation through new product launches, such as Neptune S and System 9, as well as strategic acquisitions, including Cerus Endovascular Limited. These efforts strengthen its market presence in instruments, endoscopy, and neurotechnology.